PMID- 35507951 OWN - NLM STAT- MEDLINE DCOM- 20220506 LR - 20230831 IS - 2380-0194 (Electronic) IS - 2380-0186 (Linking) VI - 35 IP - 4 DP - 2022 May 1 TI - Cervical Disc Replacement for Radiculopathy Versus Myeloradiculopathy: An MCID Analysis. PG - 170-175 LID - 10.1097/BSD.0000000000001313 [doi] AB - STUDY DESIGN: Retrospective cohort study. OBJECTIVES: The aim was to compare the minimally clinically important difference (MCID) across multiple patient-reported outcomes (PROs) in patients undergoing cervical disc replacement (CDR) for cervical spondylotic radiculopathy versus myeloradiculopathy. SUMMARY OF BACKGROUND DATA: To date, a limited number of studies have demonstrated mostly similar results in patients with cervical spondylotic radiculopathy or myeloradiculopathy undergoing CDR. However, each of these previous studies have focused on statistically significant differences, which may not correlate with patient perceived improvements in outcomes or success. METHODS: Patients who underwent 1 or 2-level CDR with radiculopathy versus myeloradiculopathy were identified, and prospectively collected data was retrospectively reviewed. Demographic variables, preoperative diagnosis, and operative variables were collected for each patient. The following PROs were prospectively collected: Neck Disability Index (NDI), visual analog scale (VAS)-Neck, VAS-Arm, Short Form-12 Health Survey (SF-12) Physical Component Score (PCS), SF-12 Mental Component Score (MCS), PROMIS Physical Function (PF). An MCID analysis of PROs for each diagnosis group was performed and the percentage of patients achieving the MCID was compared between the two diagnosis groups. RESULTS: Eight-five patients, of which 56% had radiculopathy and 44% had myeloradiculopathy. MCID analysis demonstrated that at 6-week, 12-week, and final postoperative follow-up there was no significant difference in the percentage of patients with radiculopathy or myeloradiculopathy achieving the MCID for each PRO assessed. In both diagnosis groups the percentage of patients achieving the MCID for each PRO continued to increase from the 6-week to final postoperative follow-up except for the SF-12 MCS in patients with myeloradiculopathy. CONCLUSIONS: The percentage of patients achieving the MCID was not significantly different at each postoperative period assessed in the radiculopathy and myeloradiculopathy groups treated with CDR. In addition, the percentage of patients achieving the MCID continued to increase from 6 weeks to final follow-up in both groups for almost all PROs assessed. CI - Copyright (c) 2022 Wolters Kluwer Health, Inc. All rights reserved. FAU - Alluri, Ram K AU - Alluri RK AD - Hospital for Special Surgery. FAU - Vaishnav, Avani S AU - Vaishnav AS AD - Hospital for Special Surgery. FAU - Sivaganesan, Ahilan AU - Sivaganesan A AD - Hospital for Special Surgery. FAU - Albert, Todd J AU - Albert TJ AD - Hospital for Special Surgery. AD - Weill Cornell Medical College, New York, NY. FAU - Huang, Russel C AU - Huang RC AD - Hospital for Special Surgery. AD - Weill Cornell Medical College, New York, NY. FAU - Qureshi, Sheeraz A AU - Qureshi SA AD - Hospital for Special Surgery. AD - Weill Cornell Medical College, New York, NY. LA - eng PT - Journal Article DEP - 20220418 PL - United States TA - Clin Spine Surg JT - Clinical spine surgery JID - 101675083 SB - IM MH - Cervical Vertebrae/surgery MH - Humans MH - *Radiculopathy/surgery MH - Retrospective Studies MH - *Spinal Cord Diseases/surgery MH - *Spondylosis/surgery MH - Treatment Outcome COIS- The authors declare no conflict of interest. EDAT- 2022/05/05 06:00 MHDA- 2022/05/07 06:00 CRDT- 2022/05/04 17:32 PHST- 2022/01/24 00:00 [received] PHST- 2022/03/01 00:00 [accepted] PHST- 2022/05/04 17:32 [entrez] PHST- 2022/05/05 06:00 [pubmed] PHST- 2022/05/07 06:00 [medline] AID - 01933606-202205000-00007 [pii] AID - 10.1097/BSD.0000000000001313 [doi] PST - ppublish SO - Clin Spine Surg. 2022 May 1;35(4):170-175. doi: 10.1097/BSD.0000000000001313. Epub 2022 Apr 18.